©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Oncol. Aug 10, 2015; 6(4): 57-63
Published online Aug 10, 2015. doi: 10.5306/wjco.v6.i4.57
Published online Aug 10, 2015. doi: 10.5306/wjco.v6.i4.57
Isolated limb infusion chemotherapy with or without hemofiltration for recurrent limb melanoma
Sara Cecchini, Stefano Ricci, Ludovico Delle Vergini, Manuela Sallei, Department of Vascular and Interventional Radiology, INRCA Hospital- IRCCS, 60127 Ancona, Italy
Donatella Sarti, Giammaria Fiorentini, Department of Oncology-Hematology, “Azienda Ospedaliera Ospedali Riuniti Marche Nord”, San Salvatore Hospital, 61122 Pesaro, Italy
Stefano Serresi, Giuseppe Ricotti, Unit of Dermatology, INRCA Hospital- IRCCS, 60127 Ancona, Italy
Luca Mulazzani, Department of Radiology, General Hospital “Azienda Ospedaliera Ospedali Riuniti Marche Nord”, 61122 Pesaro, Italy
Fabrizia Lattanzio, Italian National Research Center on Aging, Scientific Direction, 60127 Ancona, Italy
Author contributions: All authors contributed to this manuscript.
Institutional review board statement: The study was reviewed and approved by the Azienda Ospedaliera “Ospedali Riuniti Marche Nord” Institutional Review Board.
Informed consent statement: All study participants, or their legal guardian, provided informed written consent before study enrollment.
Conflict-of-interest statement: There is no conflict of interest.
Data sharing statement: No additional data are available.
Correspondence to: Dr. Giammaria Fiorentini, Department of Oncology-Hematology, “Azienda Ospedaliera Ospedali Riuniti Marche Nord”, PO San Salvatore, via C. Lombroso 1, 61122 Pesaro, Italy. giammaria.fiorentini@ospedalimarchenord.it
Telephone: +39-721-364124 Fax: +39-721-364094
Received: December 19, 2014
Peer-review started: December 22, 2014
First decision: March 6, 2015
Revised: April 22, 2015
Accepted: June 15, 2015
Article in press: June 16, 2015
Published online: August 10, 2015
Processing time: 240 Days and 19.1 Hours
Peer-review started: December 22, 2014
First decision: March 6, 2015
Revised: April 22, 2015
Accepted: June 15, 2015
Article in press: June 16, 2015
Published online: August 10, 2015
Processing time: 240 Days and 19.1 Hours
Core Tip
Core tip: Isolated limb infusion (ILI) is a regional treatment of limb melanoma, allowing selective delivery of toxic agents to the arm or leg with the tumor, with limited leakage. Hemofiltration can reduce the high toxic peaks of drug in the blood, hence, limiting post-procedural side effects. In this paper we report results of an Italian Registry applying the ILI technique with or without Hemofiltration to recurrent non-resectable limb melanoma. The overall response rate was 66%. Low grade toxicity was observed in 90% of patients. ILI with/without hemofiltration is an efficacious and safe treatment for recurrent non-resectable limb melanoma.